We propose that before the recognized oncogenic pathways are activated, four key DEGs (BMI1, NOP56, UBE2E1, and FAM98A) are aberrantly expressed, revealing the different prognoses of patients with liver cancer. Here, UBE2E1 is linked to liver cancer.